Ftse Mib
33.414,56
0,46%
DAX
19.626,45
1,05%
S&P 500
6.032,38
0,56%
NASDAQ
19.218,17
0,83%
Bitcoin
96.845,05
-0,66%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Biogen Inc (IDP) Biogen Inc (IDP) Notizie

Biogen Inc

IDP
152,00
-0,75 (-0,49%)
29 Nov 2024 - Chiuso
Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
19/11/202407:00UKREGDapirolizumab Pegol Phase 3 Data Presented at the American..
14/11/202417:23UKREGEisai Receives Positive Opinion from the CHMP in the..
31/10/202400:30UKREGEisai Presents Data on Benefits of Long-Term Administration..
29/10/202423:00UKREGBiogen and Neomorph Announce Multi-Target Research..
29/10/202413:00UKREGBiogen Appoints Daniel Quirk, MD, as Chief Medical Officer
28/10/202413:30UKREGMichael McDonnell, Executive Vice President and Chief..
27/10/202402:15UKREGBiogen Presents Positive Results from Phase 2 IGNAZ Study of..
24/10/202413:30UKREGBiogen to Present New Data at the Clinical Trials on..
22/10/202413:30UKREGBiogen Announces Late Breaker and New Data Presentations at..
09/10/202413:30UKREGBiogen Receives U.S. FDA Breakthrough Therapy Designation..
08/10/202413:30UKREGNew Higher Dose Nusinersen Efficacy and Safety Data..
24/9/202407:00UKREGUCB and Biogen Announce Positive Topline Results From Phase..
12/9/202413:30UKREGBiogen Board Appoints Two New Independent Directors
04/9/202413:30UKREGBiogen Announces Positive Topline Results from Study of..
30/7/202423:15UKREGNew Clinical Data Demonstrates Three Years of Continuous..
30/7/202413:30UKREGBiogen, Beckman Coulter and Fujirebio to Collaborate on..
26/7/202413:20UKREGUpdate on Regulatory Review of Lecanemab for Early..
02/7/202415:16GLOBEBiogen Completes Acquisition of Human Immunology Biosciences
28/6/202401:39GLOBE“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s..
24/6/202413:30GLOBETOFIDENCE™ (tocilizumab), a Biosimilar Referencing..
10/6/202401:37GLOBEFDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb)..
30/5/202422:51GLOBEBiogen Receives European Commission Approval for..
22/5/202413:30GLOBEBiogen Bolsters Late-Stage Pipeline, Expands Immunology..
16/5/202413:30GLOBEBiogen and Ionis Announce Topline Phase 1/2 Study Results of..
15/5/202401:33GLOBEEisai Initiates Rolling Biologics License Application to US..
25/4/202422:05GLOBEBiogen Receives Positive CHMP Opinion for TOFIDENCE™..
06/3/202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04/3/202422:15GLOBEBiogen Highlights New Data at the International Conference..
23/2/202413:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
12/2/202422:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
31/1/202413:30GLOBEBiogen to Realign Resources for Alzheimer's Disease..
19/12/202313:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202315:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202312:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
Apertura: 152,90 Min: 150,45 Max: 153,00
Chiusura: 152,75

La tua Cronologia

TG
IDP
Biogen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network